1996
DOI: 10.1016/s0753-3322(96)89681-8
|View full text |Cite
|
Sign up to set email alerts
|

Endothelium and biomaterials: Morpho-functional assessments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…An alternative to homografts are synthetic grafts [3][4][5][6]. Synthetic grafts generally have a lower level of patency because practically all materials are somewhat thrombogenic and clogging of implanted grafts is a common problem [7]. To solve this problem, many different approaches, including a variety of anti-thrombogenic coatings [6,8] and endothelial cell seeding [9,10], have been tried.…”
Section: Introductionmentioning
confidence: 99%
“…An alternative to homografts are synthetic grafts [3][4][5][6]. Synthetic grafts generally have a lower level of patency because practically all materials are somewhat thrombogenic and clogging of implanted grafts is a common problem [7]. To solve this problem, many different approaches, including a variety of anti-thrombogenic coatings [6,8] and endothelial cell seeding [9,10], have been tried.…”
Section: Introductionmentioning
confidence: 99%
“…When autografts are not available, synthetic grafts made from Dacron, expanded poly(tetrafluoroethylene) (ePTFE), or polyurethane are used. Synthetic vascular grafts are freely available but clogging, compliance mismatch, and fibrous tissue formation are major problems leading in some cases to graft failure . Different approaches including antithrombogenic coatings, endothelial cell seeding, , and modification of pore size and surface texture have been tried to solve them. Even though these approaches improved the performance of the synthetic grafts, they were still limited to the treatment of large arteries (>6 mm inner diameter).…”
Section: Introductionmentioning
confidence: 99%
“…Up to now, meeting this challenge has been mostly attempted by fabricating porous scaffolds [178], which provides sufficient space for vascularization. However, this approach cannot overcome the vascularization challenge completely due to the diffusion of cells and other materials into these porous structures [179]. Evidently, advances in bioprinting technologies will provide potential solutions to overcome this problem while forming interconnected, well-defined vascular structures during biomanufacturing process.…”
Section: Future Perspective and Challengesmentioning
confidence: 99%